Cardiac vagal activity: a target for intervention in heart disease
- 15 April 1995
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 345 (8955), 937-938
- https://doi.org/10.1016/s0140-6736(95)90694-0
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Scopolamine improves autonomic balance in advanced congestive heart failure.Circulation, 1994
- Effects of converting enzyme inhibition on heart period variability in patients with acute myocardial infarction.Circulation, 1994
- Power spectrum analysis of heart rate variability: a tool to explore neural regulatory mechanisms.Heart, 1994
- Low doses of scopolamine increase cardiac vagal tone in the acute phase of myocardial infarction.Circulation, 1993
- Controlled trial of physical training in chronic heart failure. Exercise performance, hemodynamics, ventilation, and autonomic function.Circulation, 1992
- Prognostic value of baroreflex sensitivity testing after acute myocardial infarction.Heart, 1992
- Protective effect of vagal stimulation on reperfusion arrhythmias in cats.Circulation Research, 1987
- Decreased heart rate variability and its association with increased mortality after acute myocardial infarctionThe American Journal of Cardiology, 1987
- Inhibition by angiotensin II of baroreceptor‐evoked activity in cardiac vagal efferent nerves in the dog.The Journal of Physiology, 1979
- Defective Cardiac Parasympathetic Control in Patients with Heart DiseaseNew England Journal of Medicine, 1971